Tim Serno

492 total citations
9 papers, 412 citations indexed

About

Tim Serno is a scholar working on Molecular Biology, Pharmaceutical Science and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tim Serno has authored 9 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Pharmaceutical Science and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tim Serno's work include Protein purification and stability (9 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Tim Serno is often cited by papers focused on Protein purification and stability (9 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Tim Serno collaborates with scholars based in Switzerland, Germany and Austria. Tim Serno's co-authors include Gerhard Winter, Raimund Geidobler, Theodore W. Randolph, John F. Carpenter, Achim Goepferich, Oliver Germershaus, Elisabeth Härtl, R. Miller, Ahmed Besheer and Christian Beerli and has published in prestigious journals such as Advanced Drug Delivery Reviews, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Tim Serno

9 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Serno Switzerland 7 302 120 111 71 48 9 412
Jinjiang Li United States 10 261 0.9× 114 0.9× 58 0.5× 100 1.4× 31 0.6× 19 392
Pierre Goldbach Switzerland 14 342 1.1× 90 0.8× 106 1.0× 60 0.8× 70 1.5× 17 438
Narendra B. Bam United States 5 448 1.5× 163 1.4× 84 0.8× 59 0.8× 63 1.3× 7 515
Eva Horn Møller Denmark 11 176 0.6× 85 0.7× 111 1.0× 99 1.4× 28 0.6× 14 391
Eva Horn Moeller Denmark 9 228 0.8× 50 0.4× 102 0.9× 52 0.7× 36 0.8× 11 352
Jun Yeul Lim South Korea 13 190 0.6× 65 0.5× 80 0.7× 30 0.4× 32 0.7× 17 340
Manohar Katakam United States 7 233 0.8× 65 0.5× 153 1.4× 43 0.6× 34 0.7× 7 417
David Bodmer Switzerland 8 186 0.6× 64 0.5× 180 1.6× 41 0.6× 47 1.0× 10 414
Cavan Kalonia United States 12 534 1.8× 264 2.2× 48 0.4× 193 2.7× 20 0.4× 23 604
Momoko Kitaoka Japan 13 184 0.6× 29 0.2× 94 0.8× 50 0.7× 21 0.4× 25 341

Countries citing papers authored by Tim Serno

Since Specialization
Citations

This map shows the geographic impact of Tim Serno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Serno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Serno more than expected).

Fields of papers citing papers by Tim Serno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Serno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Serno. The network helps show where Tim Serno may publish in the future.

Co-authorship network of co-authors of Tim Serno

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Serno. A scholar is included among the top collaborators of Tim Serno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Serno. Tim Serno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bechtold-Peters, Karoline, Beate Beyer, Swen Zierow, et al.. (2023). An Intra-Company Analysis of Inherent Particles in Biologicals Shapes the Protein Particle Mitigation Strategy Across Development Stages. Journal of Pharmaceutical Sciences. 112(5). 1476–1484. 4 indexed citations
2.
Serno, Tim, et al.. (2023). Modular and tunable alternative surfactants for biopharmaceuticals provide insights into Surfactant’s Structure-Function relationship. International Journal of Pharmaceutics. 650. 123692–123692. 3 indexed citations
3.
Serno, Tim, et al.. (2023). Not the Usual Suspects: Alternative Surfactants for Biopharmaceuticals. ACS Applied Materials & Interfaces. 15(29). 34540–34553. 14 indexed citations
4.
Serno, Tim, et al.. (2014). Controlled release of therapeutic antibody formats. European Journal of Pharmaceutics and Biopharmaceutics. 88(2). 291–309. 43 indexed citations
5.
Serno, Tim, et al.. (2013). Understanding the Freezing of Biopharmaceuticals: First-Principle Modeling of the Process and Evaluation of Its Effect on Product Quality. Journal of Pharmaceutical Sciences. 102(8). 2495–2507. 29 indexed citations
6.
Voštiar, Igor, Annabelle Heier, Tim Serno, et al.. (2013). Pharmacokinetics, biocompatibility and bioavailability of a controlled release monoclonal antibody formulation. Journal of Controlled Release. 172(3). 975–982. 22 indexed citations
7.
Serno, Tim, Elisabeth Härtl, Ahmed Besheer, R. Miller, & Gerhard Winter. (2012). The Role of Polysorbate 80 and HPβCD at the Air-Water Interface of IgG Solutions. Pharmaceutical Research. 30(1). 117–130. 42 indexed citations
8.
Serno, Tim, Raimund Geidobler, & Gerhard Winter. (2011). Protein stabilization by cyclodextrins in the liquid and dried state. Advanced Drug Delivery Reviews. 63(13). 1086–1106. 153 indexed citations
9.
Serno, Tim, John F. Carpenter, Theodore W. Randolph, & Gerhard Winter. (2009). Inhibition of Agitation‐Induced Aggregation of an IgG‐Antibody by Hydroxypropyl‐β‐Cyclodextrin. Journal of Pharmaceutical Sciences. 99(3). 1193–1206. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026